Chemplast Sanmar Limited (BOM:543336)
India · Delayed Price · Currency is INR 318.05
-15.75 (-4.72%)
At close: Feb 13, 2026
Chemplast Sanmar Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 41,191 | 43,461 | 39,230 | 49,411 | 58,920 | 37,987 |
Revenue | 41,191 | 43,461 | 39,230 | 49,411 | 58,920 | 37,987 |
Revenue Growth (YoY) | -2.99% | 10.79% | -20.61% | -16.14% | 55.10% | 202.05% |
Cost of Revenue | 27,102 | 27,529 | 27,082 | 32,117 | 37,150 | 21,222 |
Gross Profit | 14,090 | 15,932 | 12,148 | 17,294 | 21,770 | 16,765 |
Selling, General & Admin | 2,715 | 2,679 | 1,756 | 1,515 | 1,235 | 1,141 |
Other Operating Expenses | 10,619 | 10,713 | 9,780 | 10,423 | 7,903 | 5,426 |
Operating Expenses | 15,538 | 15,381 | 13,049 | 13,358 | 10,509 | 7,878 |
Operating Income | -1,448 | 550.4 | -901.2 | 3,936 | 11,261 | 8,887 |
Interest Expense | -1,318 | -1,283 | -867.2 | -722.6 | -2,394 | -3,612 |
Interest & Investment Income | 401.8 | 401.8 | 598.4 | 643.1 | 338.6 | 123.12 |
Earnings From Equity Investments | - | - | - | - | - | -3,336 |
Currency Exchange Gain (Loss) | -314.6 | -314.6 | -337.9 | -527.7 | -631.8 | -548.6 |
Other Non Operating Income (Expenses) | -1,178 | -1,060 | -928.4 | -808.8 | -811.8 | -715.5 |
EBT Excluding Unusual Items | -3,857 | -1,705 | -2,436 | 2,520 | 7,762 | 798.31 |
Merger & Restructuring Charges | - | - | - | - | - | -156.84 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 4,828 |
Gain (Loss) on Sale of Assets | 13.9 | 13.9 | 180.6 | 0.2 | 193.2 | - |
Asset Writedown | - | - | - | -805 | - | - |
Pretax Income | -3,843 | -1,691 | -2,256 | 1,715 | 7,956 | 5,470 |
Income Tax Expense | -956.2 | -587.1 | -671.4 | 191.6 | 1,469 | 1,369 |
Net Income | -2,887 | -1,104 | -1,584 | 1,524 | 6,487 | 4,101 |
Net Income to Common | -2,887 | -1,104 | -1,584 | 1,524 | 6,487 | 4,101 |
Net Income Growth | - | - | - | -76.51% | 58.17% | 789.07% |
Shares Outstanding (Basic) | 159 | 158 | 158 | 158 | 149 | 134 |
Shares Outstanding (Diluted) | 159 | 158 | 158 | 158 | 149 | 134 |
Shares Change (YoY) | -0.18% | - | - | 6.43% | 10.80% | -40.59% |
EPS (Basic) | -18.20 | -6.98 | -10.02 | 9.64 | 43.66 | 30.59 |
EPS (Diluted) | -18.20 | -6.98 | -10.02 | 9.64 | 43.66 | 30.59 |
EPS Growth | - | - | - | -77.93% | 42.75% | 1399.27% |
Free Cash Flow | - | -2,106 | -8,639 | -641.6 | 7,885 | 10,210 |
Free Cash Flow Per Share | - | -13.32 | -54.64 | -4.06 | 53.07 | 76.15 |
Gross Margin | 34.21% | 36.66% | 30.97% | 35.00% | 36.95% | 44.13% |
Operating Margin | -3.52% | 1.27% | -2.30% | 7.97% | 19.11% | 23.40% |
Profit Margin | -7.01% | -2.54% | -4.04% | 3.08% | 11.01% | 10.79% |
Free Cash Flow Margin | - | -4.84% | -22.02% | -1.30% | 13.38% | 26.88% |
EBITDA | 849.25 | 2,496 | 575.6 | 5,319 | 12,596 | 10,162 |
EBITDA Margin | 2.06% | 5.74% | 1.47% | 10.76% | 21.38% | 26.75% |
D&A For EBITDA | 2,298 | 1,946 | 1,477 | 1,383 | 1,335 | 1,275 |
EBIT | -1,448 | 550.4 | -901.2 | 3,936 | 11,261 | 8,887 |
EBIT Margin | -3.52% | 1.27% | -2.30% | 7.97% | 19.11% | 23.40% |
Effective Tax Rate | - | - | - | 11.17% | 18.46% | 25.03% |
Revenue as Reported | 41,544 | 43,931 | 40,035 | 50,210 | 59,495 | 38,151 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.